Jiangsu Apon Medical Technology Co., Ltd.
Symbol: 300753.SZ
SHZ
12.98
CNYTrhová cena dnes
-103.9099
Pomer P/E
0.0000
Pomer PEG
1.64B
MRK Cap
- 0.00%
Výnos DIV
Jiangsu Apon Medical Technology Co., Ltd. (300753-SZ) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 249.3 | 274.7 | 388.6 | |||||||||
balance-sheet.row.short-term-investments | 0 | -22.7 | -7.6 | -1.5 | |||||||||
balance-sheet.row.net-receivables | 0 | 133.6 | 139.2 | 102.3 | |||||||||
balance-sheet.row.inventory | 0 | 61 | 67.4 | 31.7 | |||||||||
balance-sheet.row.other-current-assets | 0 | 1.5 | 2.9 | 0.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 445.4 | 484.2 | 523.3 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 207 | 212.8 | 168.6 | |||||||||
balance-sheet.row.goodwill | 0 | 53.2 | 69.4 | 33.9 | |||||||||
balance-sheet.row.intangible-assets | 0 | 35.6 | 33.2 | 37.7 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 88.8 | 102.6 | 71.6 | |||||||||
balance-sheet.row.long-term-investments | 0 | 103.8 | 87 | 60.5 | |||||||||
balance-sheet.row.tax-assets | 0 | 24.4 | 8.7 | 2.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 0.8 | 3.7 | 1.2 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 424.8 | 414.9 | 303.9 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.account-payables | 0 | 46.9 | 27.8 | 31.4 | |||||||||
balance-sheet.row.short-term-debt | 0 | 33.8 | 2 | -3.4 | |||||||||
balance-sheet.row.tax-payables | 0 | 6.6 | 8.5 | 14.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 34.5 | 39.9 | 3.7 | |||||||||
Deferred Revenue Non Current | 0 | 1.9 | 2 | 2 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 1.6 | 42.3 | 53.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 36.7 | 42 | 2.2 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 34.5 | 39.9 | 3.7 | |||||||||
balance-sheet.row.total-liab | 0 | 183.9 | 118.5 | 87.4 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 126 | 126 | 105 | |||||||||
balance-sheet.row.retained-earnings | 0 | 188.1 | 264.5 | 247.1 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 41.5 | 41.5 | 36.5 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 329.9 | 347.6 | 350.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 685.6 | 779.6 | 739.5 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 870.2 | 899.1 | 827.2 | |||||||||
balance-sheet.row.minority-interest | 0 | 0.8 | 0.9 | 0.3 | |||||||||
balance-sheet.row.total-equity | 0 | 686.4 | 780.5 | 739.8 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 81.1 | 79.4 | 59 | |||||||||
balance-sheet.row.total-debt | 0 | 68.4 | 39.9 | 3.7 | |||||||||
balance-sheet.row.net-debt | 0 | -180.9 | -234.8 | -384.8 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -76.5 | 53.3 | 96.9 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 15.5 | 6.6 | -0.7 | |||||||||
cash-flows.row.change-in-working-capital | 0 | 28.3 | -76.7 | -25.8 | |||||||||
cash-flows.row.account-receivables | 0 | 9.1 | -47.6 | -34 | |||||||||
cash-flows.row.inventory | 0 | 6.3 | -33.6 | -3.3 | |||||||||
cash-flows.row.account-payables | 0 | 28.4 | 11.1 | 10.7 | |||||||||
cash-flows.row.other-working-capital | 0 | -15.5 | -6.6 | 0.7 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 4.1 | 26.3 | 2.6 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.acquisitions-net | 0 | 0.1 | -37.3 | 2.7 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -3 | -22.5 | -52.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 259 | 0.1 | 0.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | -256.7 | 2.5 | 1.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -24.8 | -96.7 | -83.1 | |||||||||
cash-flows.row.debt-repayment | 0 | -29.4 | 0 | -0.4 | |||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | -0.6 | -31.5 | -32.3 | |||||||||
cash-flows.row.other-financing-activites | 0 | 54 | -4.3 | 0.4 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 23.9 | -35.8 | -32.3 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -25.5 | -114.3 | -32 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 248.8 | 274.3 | 388.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 274.3 | 388.6 | 420.6 | |||||||||
cash-flows.row.operating-cash-flow | 0 | -24.6 | 18.3 | 83.3 | |||||||||
cash-flows.row.capital-expenditure | 0 | -24.2 | -39.6 | -35.6 | |||||||||
cash-flows.row.free-cash-flow | 0 | -48.8 | -21.3 | 47.7 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 323.8 | 461.2 | 443.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 163.8 | 166.3 | 188.6 | |||||||||
income-statement-row.row.gross-profit | 0 | 160 | 294.9 | 254.5 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.operating-expenses | 0 | 232 | 235.5 | 146.3 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 395.7 | 401.8 | 334.9 | |||||||||
income-statement-row.row.interest-income | 0 | 2.1 | 3.6 | 7.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -2.4 | -0.5 | -1.6 | |||||||||
income-statement-row.row.interest-expense | 0 | 2.5 | 1.1 | 0 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 19.6 | 15.4 | 9.7 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | -88.3 | 55.8 | 113.5 | |||||||||
income-statement-row.row.income-before-tax | 0 | -90.7 | 55.3 | 111.9 | |||||||||
income-statement-row.row.income-tax-expense | 0 | -14.2 | 2 | 15 | |||||||||
income-statement-row.row.net-income | 0 | -76.4 | 54.1 | 97 |
Často kladené otázky
Čo je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) celkové aktíva?
Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) celkové aktíva sú 870213234.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.567.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je -0.266.
Aká je čistá zisková marža podniku?
Čistá zisková marža je -0.043.
Aké sú celkové výnosy podniku?
Celkové príjmy sú -0.061.
Aká je Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je -76377405.540.
Aký je celkový dlh firmy?
Celkový dlh je 68373296.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 231973871.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.